CARGO Therapeutics Inc. (CRGX): Fair Value Consensus

Corporate company logo of Cargo Therapeutics (CRGX)

Global political instability and sanctions seriously hinder cross-border trials and the movement of biomaterials. Meanwhile, stringent FDA oversight and complex genetic engineering patents create insurmountable barriers for new entrants. This daily price chart for CARGO Therapeutics (CRGX), with a value of 7.04, reflects the dynamics of a brand with high scientific standing in the development of advanced oncology treatments.

CARGO Therapeutics Inc. (CRGX) Consensus Target: for the period 02/21/2024 - 08/30/2025

Metric breakdowns and analytics for CARGO Therapeutics, Inc. (CRGX)

- market price and analyst price targets:
Stock Quotes CARGO Therapeutics Inc.|CRGX - Price Target Chart
- stock exchange capitalization data:
Market Value CARGO Therapeutics, Inc|CRGX - Enterprise Value
- book capitalization indicators:
Book Value of One Share CARGO Therapeutics|CRGX - Company Net Assets|Capitalization to Book Value Ratio cargo-tx.com|CRGX - Aggregate Company Assets
- debt obligations and liquidity statistics:
Debt to Capital CARGO Therapeutics|CRGX - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio CARGO Therapeutics|CRGX - Company Aggregate Debts|Debt to Book Value CARGO Therapeutics|CRGX - Company Long-Term Debt|Short-Term Debt CARGO Therapeutics|Quick Liquidity cargo-tx.com
- earnings and market multiples details:
CRGX - Company Net Income|Expected Net Profit CARGO Therapeutics|CRGX - P/E Multiple|Forward Price to Earnings Multiple CARGO Therapeutics|CRGX - Price/Earnings to Growth Multiple|Company Value to EBITDA CARGO Therapeutics, Inc.|CRGX - Operating profit before deduction of amortization|Earnings per share for the trailing year CARGO Therapeutics|CRGX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months cargo-tx.com|CRGX - Earnings growth in current year|Expected net earnings per share growth next year CARGO Therapeutics
- sales revenue and business income indicators:
CRGX - Company Revenue|Company Projected Revenue CARGO Therapeutics Inc.|CRGX - Price-to-Revenue Ratio|Price-to-Projected Revenue Ratio CARGO Therapeutics, Inc.|CRGX - Revenue Growth YoY (Last 12 Months)
General company analysis:CRGX (CARGO Therapeutics Inc.)
Mass-produced product of cargo-tx.com

High demand for CAR-T therapy for resistant lymphomas makes investments in CARGO Therapeutics (CRGX) dependent on the accuracy of market expectations. The analysts' consensus target for the stock aggregates professional valuation estimates, allowing investors to distinguish fundamental business degradation from temporary drawdowns and avoid value traps when attempting to time the price bottom, thereby verifying the real potential for capital growth.

Competitors of CARGO Therapeutics

Price Target Chart LEGN (Legend Biotech Corporation)|Analyst Consensus Forecast SANA (Sana Biotechnology Inc)|Analyst Consensus Forecast Autolus Therapeutics AUTL|ALLO - Price Target Chart|RNAC - Analyst Consensus Forecast|Cellectis S.A. (CLLS) - Price Target Chart|Caribou Biosciences Inc. (CRBU) - Analyst Consensus Forecast|Price Target Chart Instil Bio, Inc.|Average Forecast Price genenta.com GNTA|Price Target Chart Century Therapeutics Inc (IPSC)|Jasper Therapeutics, Inc. - Broker Consensus Forecast|Analyst Consensus Forecast SNTI (Senti Biosciences, Inc.)|ADAP - Consensus Target|CERO - Price Target Chart|Average Forecast Price Alaunos Therapeutics, Inc.|Achilles Therapeutics PLC (ACHL) - Price Target Chart|PSTX (poseida.com) - Price Target Chart|Price Target Chart 2seventy bio, Inc|Average Forecast Price Gracell Biotechnologies Inc. GRCL